Elixinol Wellness Limited ELLXF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 2.29% | -3.14% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.29% | -2.86% | |||
| Cost of Revenue | 2.29% | -9.51% | |||
| Gross Profit | 2.29% | 7.52% | |||
| SG&A Expenses | 2.28% | -26.32% | |||
| Depreciation & Amortization | 2.31% | 10.47% | |||
| Other Operating Expenses | 1.52% | 107.28% | |||
| Total Operating Expenses | 2.29% | -14.33% | |||
| Operating Income | -2.25% | 63.66% | |||
| Income Before Tax | -2.28% | 65.02% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.28% | 57.25% | |||
| Earnings from Discontinued Operations | -2.35% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.29% | 52.94% | |||
| EBIT | -2.25% | 63.66% | |||
| EBITDA | -2.29% | 82.80% | |||
| EPS Basic | 0.00% | 66.67% | |||
| Normalized Basic EPS | -25.00% | 75.00% | |||
| EPS Diluted | 0.00% | 66.67% | |||
| Normalized Diluted EPS | -25.00% | 75.00% | |||
| Average Basic Shares Outstanding | 0.00% | 42.63% | |||
| Average Diluted Shares Outstanding | 0.00% | 42.63% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||